Lacosamide IV for stopping prolonged seizures
Treatments studied
Part of Brain & nervous system clinical trials.
This study tests a medication called lacosamide given through an IV to stop a prolonged seizure (status epilepticus) quickly. It aims to see if it is effective and safe for people having a medical emergency caused by seizures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 4 and 60 years old.
- You must be having a seizure that lasts longer than 5 minutes, or have repeated seizures without regaining consciousness in between.
- The seizure must be considered status epilepticus (a medical emergency).
- Your vital signs (like heart rate and breathing) must be stable.
- You must not have certain heart rhythm problems (like atrial fibrillation or heart block).
- You must not be allergic to the study drug (lacosamide).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for adults in the intensive care unit who are having seizures that last at least 5 minutes or keep coming back without fully recovering. It tests a study approach for managing a dangerous seizure emergency and may help doctors improve care for critically ill patients.
This trial tests if adding ketamine to standard care can stop seizures that continue after a first treatment. It is for people having a convulsive seizure lasting more than 5 minutes and who are still seizing in the emergency room.
This trial studies whether using EEG (a brain-wave test) in the ICU can help guide care for people whose seizures keep going despite initial medicines. It may benefit patients with severe, difficult-to-stop status epilepticus by improving how doctors find and treat ongoing seizure activity.
This trial tests whether taking ketone esters (a special form of ketones) can help stop refractory generalized convulsive status epilepticus (a seizure emergency that is hard to control). If you qualify, the study team will check safety closely, especially your breathing, heart stability, and blood sugar/acid levels.
This Phase 2 trial tests a medication strategy to stop “refractory status epilepticus,” a severe seizure condition that can happen after a cardiac arrest. It may help by reducing ongoing seizure activity after return of circulation in the ICU.
This study tests a seizure-prevention medicine called perampanel for people whose hearts stopped beating (cardiac arrest) and are now in the ICU. The goal is to see if it helps prevent seizures that can happen after such an event.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.